Diabetech - Diabetes Tech, Research, News

We dive into growing concerns around reliability issues with the Dexcom G7. After posting a video online that sparked nearly 1,000 comments from users reporting sensor failures, it became clear that this wasn’t an isolated problem. To explore what’s going on, I’m joined by two experts in the diabetes space: Kamil of the Nerdabetic YouTube channel, and Dr. David Ahn, a practicing endocrinologist. We discuss the recent FDA warning letter Dexcom received, reports of sensor connectivity failures and applicator issues like “goosenecking,” and whether Dexcom is facing scrutiny simply because of its popularity. Most importantly, we talk about the need for better transparency and communication with users.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Today we explore the evolution of continuous glucose monitors (CGMs) — from the first professional CGM in 1999 to the advanced tech driving today’s AID systems, and how these devices changed patient lives along the way. Dr. Grazia Aleppo, a leading endocrinologist and early CGM believer, joins to discuss early CGM innovations, the challenges of adoption, and pivotal research that expanded global access. Plus, we look ahead to what the future of CGM technology might hold. Have you used any of these CGMs? Let us know what it was like in the comments on Youtube.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

I sit down with someone who wore the first consumer insulin pump—the AutoSyringe We dive into what diabetes treatment was like at the time, how the early pump worked, and how decades of evolving tech have shaped her journey and inspired her to educate others. It’s a powerful look at how far we’ve come in diabetes innovation.    Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

I sit down with veteran game developer and T1D dad Sam Glassenberg, creator of Level One—a new smartphone game designed to teach newly diagnosed patients and their families the fundamentals of T1D management. From insulin-to-carb ratios to the impact of exercise and fat on blood sugar, Level One turns complex concepts into fun, interactive levels. With early praise from endocrinologists and patients alike, this could be the educational tool we’ve all been waiting for.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Mark Tapsack, CSO with a materials science and implantable sensor background, and Paul Good, CEO who helped build early Dexcom tech, discuss Glucotrack. They explain intravascular blood sensing, how an implantable CBGM could reduce delays versus interstitial CGMs, device design and chemistry, implantation approach, trial results, and potential impact on automated insulin delivery.

I share my experience after nearly three months using the Tandem Mobi, the smallest tubed hybrid closed-loop pump currently available in the U.S. I’m joined by diabetes educator and fellow Mobi user David Mina to dive deep into how Tandem’s Control-IQ algorithm works — including updates with Control-IQ+ — and what to consider before switching from other pumps like the Omnipod. We also discuss David’s journey to becoming an educator, his experience with various pumps, and why he sticks with Tandem. I talk about my own transition from a tubeless system, why I’m loving the Mobi’s quick bolus button, and my growing excitement for the upcoming Twiist pump.    Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

We take a journey back to the roots of the #WeAreNotWaiting movement—before CGM follower apps—when a group of determined parents and developers built their own tools to monitor glucose remotely. I sit down with James Wedding, founder of the Nightscout Foundation, to talk about the early days of Nightscout, how it transformed life for families managing diabetes, and the powerful role the open-source community played in pushing the industry forward. From DIY setups and the iconic “Rig” to smartwatches displaying real-time glucose data, this conversation highlights the innovation, urgency, and community spirit that made Nightscout a vital part of diabetes tech history.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

In this episode, we dive into the major shift happening in the U.S. diabetes tech industry: insulin pumps are moving from Durable Medical Equipment (DME) to pharmacy benefits, offering easier access, lower costs, and more flexibility for users. I’m joined by Jeff DelVerne, author of The Healthcare Economy Substack and Director of Payer Relations at Beta Bionics, to break down what this transition means for people with diabetes. We discuss how moving pumps to pharmacy benefits could encourage faster innovation and give users more freedom to switch devices — while also examining potential challenges, like the risk of insurers introducing tiered pump coverage similar to drug formularies.     Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

In this episode, I sit down with Amy Tenderich, one of the first diabetes bloggers, whose open letter to Steve Jobs called for better, more user-friendly diabetes technology. That bold move launched her deeper into the world of diabetes advocacy and innovation, eventually leading her to create D-Data Exchange—a powerful forum where industry leaders, regulators, and patient voices come together to push diabetes tech forward. We talk about what it was like advocating before social media, the origins of the “We Are Not Waiting” movement, and how D-Data is now helping shape critical conversations—like the one I’ll be moderating this June at ADA on GLP-1s.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Can we stop type 1 diabetes before it starts? I’m joined by Sam Reich, CEO of SAB Bio, and Dr. Mike Haller, a leading T1D researcher, to explore an innovative new therapy called SAB-142. Unlike traditional thymoglobulin, which is derived from rabbits, SAB’s therapy uses a fully human version produced by genetically engineered cows—potentially eliminating harmful side effects like serum sickness. We unpack how this treatment could delay or prevent the onset of type 1 diabetes and how it builds on research behind Teplizumab. Plus, we talk about the pivotal role NIH funding plays in advancing diabetes innovation. If you're curious about the future of diabetes prevention, you won’t want to miss this.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.